Clinical Microbiology-2012
Participants List from Academia
Untitled Document
University of Texas at Arlington, USA
Stanford University School of Medicine, USA
Mahidol University, Thailand
Amirkabir University of Technology, Iran
Hamdard University, India
Yeshiva University, USA
University of Macau, China
Monash University, Australia
University of Michigan, Ann Arbor
Universidade Federal do Rio de Janeiro, Brazil
University of Denver, Colorado
University of Toronto, Canada
Zagazig University, Egypt
Banaras Hindu University, India
Taipei Medical University, Taiwan
University di Messina CNISM, Italy
University of Tasmania, Australia
Huazhong University of Science and Technology, China
Sogang University, Korea
University of Edinburgh, UK
Martin-Luther-University Halle-Wittenberg, USA
Universidade de Sao Paulo, Brazil
Eve University, Turkey
University of Delhi, India
Isfahan University of Technology(IUT), Iran
Taif University, Saudi Arabia
University Medical Center, Netherlands
University of Copenhagen, Denmark
University Paris 13, France
Participants List from Business
Untitled Document
Cadila Pharmaceuticals, India
Chemical Works of Gedeon Richter, Hungary
3S-Pharmacological Consultation & Research GmbH, Germany
Royal Brisbane and Women's Hospital, Australia
Psoriasis and Cutaneous Inflammation Research Laboratory, USA
Alcon Laboratories Inc., USA
National Institute for Materials Science (NIMS), Japan
Grup de Recerca de Reumatologia (IRHVH), Spain
Bayer Health Care, Richmond, USA
Crown Bioscience Inc., China
Hammersmith Hospital, London
Van Drie Research LLC, USA
Dr.Reddy's labs, India
Merck Research Laboratories, USA
National Institute of Pharmaceutical Education and Research (NIPER), India
AstraZeneca R&D Boston, USA
Abbott Laboratories, USA
Hutchison MediPharma Limited, China
Sage Bionetworks, USA
Central Drug Research Institute, India
Glenmark Pharmaceuticals, India
National Institute for Interdisciplinary Science & Technology (NIIST) , India
Novartis Campus, Austria
Upcoming Conferences
International Conference on Clinical Microbiology & Microbial Genomics, Clinical Microbiology-2012 , will be organized around the theme "Exploring new Territories to fight Microbial Resistance".
Clinical Microbiology-2012 is comprised of 10 tracks and 71 sessions designed to offer comprehensive sessions that address current issues in Clinical Microbiology & Microbial Genomics.
Submit your abstract to any of the following tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Renowned Speakers
Bradford Powell
Cernomics Solutions, USA
Joel K Weltman
Brown University School of Medicine, USA
Menachem Shoham
Case Western Reserve University, USA
Duncan D Adams
University of Otago Medical School, New Zealand
Phillip J. Brumm
C5-6 Technologies, USA
Todd DeSantis
Second Genome, USA
Peter D. Karp
SRI Bioinformatics Research Group, USA
Ayman M. Noreddin
Hampton University, USA
Pascal M. Dohmen
University of Leipzig, Germany
Guangming Zhong
University of Texas, USA
Tibor Valyi-Nagy
University of Illinois, USA
Mohamad Aljofan
Monash University, Australia
Roper Rachel
East Carolina University, USA
Nora Beatriz Molina
National University of La Plata (UNLP), Argentina
Track 1 : Microbiology-Basic Science
Track 1-1
Microbial ecology
Track 1-2
Pharmaceutical microbiology
Track 1-3
Food microbiology
Track 1-4
Agricultural microbiology
Track 1-5
Biofilm
Track 2 : Antimicrobials & Microbial Techniques
Track 2-1
Mechanism of action and resistance
Track 2-2
Resistance surveillance
Track 2-3
Antimicrobials & clinical trials
Track 2-4
Surveys of molecular epidemiology of resistance and resistance genes
Track 2-5
In vitro antibacterial susceptibility and drug interaction studies
Track 2-6
Microbial strains & antibiotic applications
Track 2-7
Advances in microbial/biochemical techniques
Track 3 : Medical Microbiology
Track 3-1
Clinical aspects of antibiotics and resistance
Track 3-2
Case studies in clinical microbiology
Track 3-3
Gastrointestinal tract (GIT) infections
Track 3-4
Liver infections: Diagnosis of hepatitis and control
Track 3-5
Urinary tract infections (UTI)
Track 3-6
Septic arthritis
Track 3-7
STD's & genital infections
Track 3-8
Clinical parasitology
Track 3-9
Clinical mycology: New therapeutic approaches in prevention of fungal infections
Track 3-10
Challenges in pediatric vaccination
Track 4 : Infection Control & Immunity
Track 4-1
Multifactorial mechanisms for regulation of inflammation
Track 4-2
Host pathogen interactions
Track 4-3
Immunity to microbial infections
Track 4-4
Usage of vaccines & therapies against infectious diseases
Track 4-5
Immune response & immune evasion & immune tolerance
Track 4-6
Microbial infection control
Track 4-7
Tuberculosis and its control
Track 4-8
Flu in 21st century
Track 4-9
Clinical epidemiology of nosocomial infections(POWI, VAP, UTI, BSI)
Track 4-10
Travel medicine, tropical and parasitic diseases
Track 5 : Diagnostics
Track 5-1
Recent trends in detection of microbial toxins
Track 5-2
Biomarkers in microbial diagnosis
Track 5-3
Methods for antibacterial susceptibility testing
Track 5-4
Epidemiology of MRSA, VRE and other gram-positives
Track 5-5
Bacterial biochemical physiology
Track 5-6
New preventive aspects for pathogenesis
Track 6: Clinical & Veternary Microbiology
Track 6-1
Madcow disease
Track 6-2
Mycobacteriosis
Track 6-3
Devil facial tumour disease
Track 6-4
Monkey pox virus
Track 6-5
Sheep, goatpox and swineflu viruses
Track 6-6
Zoonoses (Rural & Urban) and their control
Track 7 :Infectious Diseases & Public Health
Track 7-1
Vector-borne zoonoses: Chagas diseases & malaria
Track 7-2
Infections arboviruses: Yellow fever & dengue
Track 7-3
Public health and community-acquired infections
Track 7-4
Emerging infectious diseases
Track 7-5
Disaster management & preventive medicine
Track 7-6
Tropical infections: Dracunculiasis
Track 8: Current Topics in the Field of Medical Microbiology
Track 8-1
Antiretroviral therapy & current research on HIV/AIDS
Track 8-2
Status of vaccine development for HIV
Track 8-3
Rabies in the U.S
Track 8-4
Eradication of polio
Track 8-5:
Clinical importance of probiotics
Track 9: Clinical Infectious Diseases
Track 9-1
Infection in the immune compromised host and transplant recepients
Track 9-2
Community-acquired infections including CAP, sepsis
Track 9-3
Pediatric infections
Track 9-4
Lyme borreliosis, toxoplasmosis
Track 9-5
Contributions of imaging techniques in hydatidosis
Track 9-6
Bacterial and fungal skin infections
Track 9-7
Diabetic Foot Infections
Track 10: Microbial Genomics
Track 10-1
Bioinformatics: sequence and genome analysis
Track 10-2
Microbial functional genomics
Track 10-3
Microarray expression analysis
Track 10-4
Single cell genomics and proteomics
Track 10-5
Metagenomics
Track 10-6
Comparitive genomics
Track 10-7
Phylogenetics
Track 10-8
Microbial genetics
Track 10-9
Genome evolution and environmental genomics